Name |
Tofacitinib, Citrate Salt
|
Supplier |
Biorbyt
|
Catalog |
orb153629
|
Prices |
$230.00, $340.00, $417.00, $434.00, $578.00, $1,046.00, $1,403.00, $2,423.00
|
Sizes |
10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g, 2 g
|
Cas Number |
[540737-29-9]
|
Pubchem |
10174505
|
Chemical Name |
2-hydroxypropane-1,2,3-tricarboxylicacid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
|
Formula |
C16H20N6O•C6H8O7
|
Molecular Weight |
504.49 g/mol
|
Purity |
>99% pure
|
Description |
Tofacitinib is also known as CP-690550, CP-690550 Citrate, Tasocitinib. It is currently approved for the treatment of rheumatoid arthritis (RA) and also for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection.
|
Supplier Page |
Shop
|